Form 4: Regeneron EVP Neil Stahl Reports Stock Gift
SEC Form 4
Neil Stahl, EVP of Research and Development at Regeneron Pharmaceuticals, reported a gift of 500 shares of common stock.
Summary
- Neil Stahl, EVP of Research and Development at Regeneron Pharmaceuticals, reported a transaction on August 13, 2024.
- The transaction involved a gift of 500 shares of common stock.
- Following the transaction, Stahl directly owns 49,599 shares of common stock.
- Stahl also indirectly owns 5,849 shares through a 401(k) plan and 4,605 shares through a spouse as trustee.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock transaction, with no inherent positive or negative sentiment.
Industry Context
This is a routine disclosure of stock transactions by a company executive, which is common in the pharmaceutical industry.
Key Dates
| Date | Description |
|---|---|
| 08/13/2024 | Date of stock gift transaction |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.